The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 19.31

All Lymphoid Neoplasms With Detailed Non-Hodgkin Lymphoma Subtypesa

SEERb 5-Year Relative Survival (Percent) by Age at Diagnosis
All Races, Females, 2006-2012
Site All Ages Ages 0-19 Ages 20-64 Ages 65+
Count Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval
Low High Low High Low High Low High
Lymphoid Neoplasm 78,287 70.4 70.0 70.8 90.5 89.5 91.5 79.8 79.3 80.3 59.9 59.2 60.6
1 Hodgkin Lymphoma 6,786 87.3 86.3 88.2 97.0 95.4 98.0 92.0 91.1 92.9 54.2 49.9 58.3
2 Non-Hodgkin lymphoma 69,445 69.3 68.8 69.7 88.6 87.2 89.8 78.0 77.4 78.6 60.7 59.9 61.4
2(a) Non-Hodgkin lymphoma, B-cell 64,459 69.5 69.0 70.0 89.1 87.6 90.4 78.7 78.0 79.3 61.1 60.4 61.9
2(a) 1. Precursor Non-Hodgkin lymphoma, B-cell 3,630 68.6 66.8 70.3 89.1 87.4 90.5 39.4 35.8 42.9 15.4 10.8 20.8
2(a) 2. Mature Non-Hodgkin lymphoma, B-cell 57,505 69.5 69.0 70.1 88.7 84.7 91.8 80.3 79.6 80.9 61.3 60.5 62.1
2(a) 2.1. Chronic/Small/Prolymphocytic/ Mantle B-cell Non-Hodgkin lymphoma 12,136 79.9 78.7 81.1 - - - 89.0 87.7 90.3 75.0 73.2 76.6
2(a) 2.1.1. Chronic/Small lymphocytic leukemia/lymphoma 11,024 82.3 81.0 83.5 - - - 91.2 89.8 92.4 77.5 75.6 79.1
2(a) 2.1.2. Prolymphocytic leukemia, B-cell 30 32.3 14.9 51.2 - - - - - - - - -
2(a) 2.1.3. Mantle-cell lymphoma 1,082 56.9 52.7 61.0 - - - 70.2 64.2 75.4 48.4 42.6 54.0
2(a) 2.2. Lymphoplasmacytic lymphoma/ Waldenstrom macroglubulinemia 1,208 82.3 78.3 85.6 - - - 91.5 87.2 94.4 76.8 70.9 81.6
2(a) 2.2.1. Lymphoplasmacytic lymphoma 590 77.3 71.2 82.3 - - - 86.6 79.1 91.5 71.9 63.1 79.0
2(a) 2.2.2. Waldenstrom macroglubulinemia 618 86.8 81.2 90.8 - - - 95.1 89.6 97.7 81.3 72.7 87.4
2(a) 2.3. Diffuse large B-cell lymphoma (DLBCL) 15,283 62.0 61.0 63.0 86.0 79.8 90.4 74.6 73.3 75.8 52.2 50.8 53.7
2(a) 2.3.1. DLBCL, NOSc 15,055 61.6 60.6 62.6 87.4 81.1 91.7 74.2 72.9 75.4 52.2 50.7 53.6
2(a) 2.3.2. Intravascular large B-cell lymphoma 27 63.0 38.7 79.9 - - - - - - - - -
2(a) 2.3.3. Primary effusion lymphoma - - - - - - - - - - - - -
2(a) 2.3.4. Mediastinal large B-cell lymphoma 197 86.3 79.7 90.9 - - - 88.2 81.5 92.5 - - -
2(a) 2.4. Burkitt lymphoma/leukemia 616 55.1 50.6 59.3 90.3 82.7 94.7 54.3 48.2 60.0 34.5 27.0 42.2
2(a) 2.5. Marginal-zone lymphoma (MZL) 5,061 89.8 88.1 91.2 - - - 93.9 92.2 95.1 86.2 83.4 88.5
2(a) 2.5.1. Splenic MZL 453 81.8 74.9 87.0 - - - 87.5 79.0 92.7 77.2 66.2 85.1
2(a) 2.5.2. Extranodal MZL, MALTc type 3,106 94.0 92.0 95.6 - - - 96.2 94.4 97.5 91.7 87.7 94.4
2(a) 2.5.3. Nodal MZL 1,502 83.1 79.8 85.9 - - - 89.7 85.8 92.6 78.3 73.2 82.5
2(a) 2.6. Follicular lymphoma 9,075 88.4 87.3 89.4 - - - 93.3 92.3 94.2 82.5 80.3 84.4
2(a) 2.7. Hairy-cell leukemia 287 89.9 82.3 94.4 - - - 97.2 92.4 99.0 73.2 54.4 85.3
2(a) 2.8. Plasma cell neoplasms 13,831 47.3 46.2 48.4 - - - 62.3 60.6 63.9 37.0 35.5 38.5
2(a) 2.8.1. Plasmacytoma 721 65.4 60.4 70.0 - - - 80.3 74.1 85.2 48.5 40.8 55.8
2(a) 2.8.2. Multiple myeloma/ plasma-cell leukemia 13,110 46.3 45.1 47.5 - - - 61.0 59.3 62.7 36.5 34.9 38.0
2(a) 2.9. Heavy chain disease - - - - - - - - - - - - -
2(a) 3. Non-Hodgkin lymphoma, B-cell, NOSc 3,324 70.4 68.0 72.6 - - - 80.1 77.1 82.8 65.3 62.0 68.4
2(b) Non-Hodgkin lymphoma, T-cell 4,297 66.3 64.5 68.0 85.3 80.7 88.8 72.2 70.1 74.2 52.5 49.0 55.8
2(b) 1. Precursor Non-Hodgkin lymphoma, T-cell 148 67.1 58.6 74.2 92.0 81.8 96.6 55.7 42.7 67.0 - - -
2(b) 2. Mature Non-Hodgkin lymphoma, T-cell 4,120 66.5 64.7 68.3 83.7 78.3 87.9 73.2 71.0 75.2 53.0 49.6 56.4
2(b) 2.1. Mycosis fungoides/Sezary syndrome 1,118 92.1 89.0 94.3 91.4 64.6 98.2 93.5 90.2 95.7 88.3 82.3 92.3
2(b) 2.1.1. Mycosis fungoides 1,088 93.3 90.1 95.5 91.4 64.6 98.2 94.2 90.9 96.3 90.0 83.9 93.9
2(b) 2.1.2. Sezary syndrome 30 42.7 20.2 63.6 - - - - - - - - -
2(b) 2.2. Peripheral T-cell lymphoma 2,338 59.4 56.9 61.7 84.8 75.3 90.8 69.3 66.3 72.1 43.4 39.2 47.5
2(b) 2.2.1. Peripheral T-cell lymphoma, NOSc 752 38.9 34.8 43.0 - - - 48.2 42.4 53.8 28.1 22.1 34.3
2(b) 2.2.2. Angioimmunoblastic T-cell lymphoma 357 47.0 40.7 53.1 - - - 62.8 53.5 70.7 35.8 27.7 44.1
2(b) 2.2.3. Subcutaneous panniculitis- like T-cell lymphoma 45 91.1 74.7 97.1 - - - 89.1 67.2 96.7 - - -
2(b) 2.2.4. Anaplastic large cell lymphoma, T-cell or null-cell type 444 63.4 57.9 68.4 82.9 69.5 90.8 71.5 65.0 77.0 32.6 21.5 44.1
2(b) 2.2.5. Hepatosplenic T-cell lymphoma - - - - - - - - - - - - -
2(b) 2.2.6. Enteropathy-type T-cell lymphoma 30 10.2 2.0 26.6 - - - - - - - - -
2(b) 2.2.7. Cutaneous T-cell lymphoma, NOSc 466 83.9 78.5 88.1 - - - 89.3 83.6 93.1 74.3 63.4 82.4
2(b) 2.2.8. Primary cutaneous anaplastic large cell lymphoma 228 90.4 82.3 94.9 - - - 94.5 87.5 97.6 78.8 56.5 90.5
2(b) 2.3. Adult T-cell leukemia/lymphoma 374 51.8 45.4 57.8 81.6 73.4 87.5 34.4 24.0 45.0 20.9 10.8 33.3
2(b) 2.4. NKc/T-cell lymphoma, nasal-type/ agressive NKc-cell leukemia 155 43.7 33.7 53.3 - - - 48.2 37.6 58.0 37.1 18.2 56.2
2(b) 2.5. T-cell large granular lymphocytic leukemia 60 75.0 58.6 85.7 - - - 82.4 62.5 92.3 63.8 37.5 81.4
2(b) 2.6. Prolymphocytic leukemia, T-cell 75 8.9 2.1 22.2 - - - 13.5 2.8 32.8 6.4 0.5 24.3
2(b) 3. Non-Hodgkin lymphoma, NOSc , T-cell 29 35.6 18.7 53.0 - - - - - - - - -
2(c) Non-Hodgkin lymphoma, unknown lineage 689 61.1 56.8 65.2 88.5 82.3 92.7 60.2 52.3 67.3 47.1 40.6 53.3
2(c) 1. Precursor lymphoblastic leukemia/ lymphoma, unknown lineage 269 67.6 61.4 73.0 89.7 83.6 93.6 40.9 27.8 53.5 21.9 10.8 35.5
2(c) 2. Prolymphocytic leukemia, unknown lineage 26 54.1 28.4 74.1 - - - - - - - - -
2(c) 3. Non-Hodgkin lymphoma, NOSc, unknown lineage 394 57.1 50.9 62.9 - - - 69.2 59.3 77.1 51.5 44.0 58.4
2(*) 1. Total precursor lymphoma/leukemiad 4,047 68.5 66.9 70.1 89.2 87.7 90.6 40.6 37.3 43.9 16.8 12.5 21.6
3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma 46 55.4 36.4 70.9 - - - 72.3 45.4 87.6 - - -
4 Lymphoid neoplasm, NOSc 2,010 51.1 48.2 53.9 84.3 61.5 94.1 67.4 63.0 71.4 42.1 38.4 45.7

Footnotes:

a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

c NOS = Not otherwise specified. MALT = Mucosa-associated lymphoid tissue. NK = Natural killer.

- Statistic not displayed due to less than 25 cases.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.